Aglamis, S., Murat Aydin, A., Eroglu, Y., Burakgazi, G., & Atmaca, M. (2021). Diffusion-weighted MRI findings of caudate nucleus and putamen in patients with obsessive-compulsive disorder. Cureus, 13, e17023.
PubMed PubMed Central Google Scholar
Al-Radaideh, A., Athamneh, I., Alabadi, H., & Hbahbih, M. (2021). Deep Gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI). European Radiology, 31, 706–715.
Benedict, R. H., Carone, D. A., & Bakshi, R. (2004). Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. Journal of Neuroimaging, 14, 36S–45S.
Chard, D. T., & Miller, D. H. (2016) What Lies beneath grey matter atrophy in multiple sclerosis? Brain 139 7–10.
Eshaghi, A., et al. (2018a). Deep Gray matter volume loss drives disability worsening in multiple sclerosis. Annals of Neurology, 83, 210–222.
CAS PubMed PubMed Central Google Scholar
Eshaghi, A., et al. (2018b). Progression of regional grey matter atrophy in multiple sclerosis. Brain, 141, 1665–1677.
PubMed PubMed Central Google Scholar
Etemadifar, M., & Sabeti, F. (2018). Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurology, 17, 497.
Fiore, A., et al. (2023). Correspondence among Gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis. Molecular Psychiatry, 28, 1770–1782.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Fujimori, J., Fujihara, K., Wattjes, M., & Nakashima, I. (2021). Patterns of cortical grey matter thickness reduction in multiple sclerosis. Brain Behav, 11, e02050.
CAS PubMed PubMed Central Google Scholar
Hamilton, M. (1959). The assessment of anxiety States by rating. British Journal of Medical Psychology, 32, 50–55.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
CAS PubMed PubMed Central Google Scholar
Han, J., et al. (2024). A study of the correlation between Gray matter atrophy in multiple sclerosis and impairment of cognitive function domains. Zhonghua Nei Ke Za Zhi, 63, 666–673.
Katz Sand, I. (2015). Classification, diagnosis, and differential diagnosis of multiple sclerosis. Current Opinion in Neurology, 28, 193–205.
Kaufman, M., Moyer, D., & Norton, J. (2000). The significant change for the timed 25-foot walk in the multiple sclerosis functional composite. Multiple Sclerosis (Houndmills, Basingstoke, England), 6, 286–290.
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–1452.
Lorefice, L., et al. (2020). The impact of deep grey matter volume on cognition in multiple sclerosis. Mult Scler Relat Disord, 45, 102351.
Nasreddine, Z. S., et al. (2005). The Montreal cognitive assessment, moca: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.
Nygaard, M. K. E., Riemenschneider, M., Gaemelke, T., Dalgas, U., & Eskildsen, S. F. (2025). Spatiotemporal alterations of Gray matter microstructure in newly diagnosed relapsing-remitting multiple sclerosis patients: A longitudinal diffusion kurtosis MRI study. Journal of the Neurological Sciences, 474, 123551.
Panahzadeh, F., Mirnasuri, R., & Rahmati, M. (2022). Exercise and Syzygium aromaticum reverse memory deficits, apoptosis and mitochondrial dysfunction of the hippocampus in alzheimer’s disease. Journal of Ethnopharmacology, 286, 114871.
Perez, C. A., Cuascut, F. X., & Hutton, G. J. (2023). Immunopathogenesis, diagnosis, and treatment of multiple sclerosis: A clinical update. Neurologic Clinics, 41, 87–106.
Rocca, M. A., et al. (2010). Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology, 257, 463–469.
Sastre-Garriga, J., et al. (2020). MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol, 16, 171–182.
PubMed PubMed Central Google Scholar
Schoonheim, M. M., et al. (2015). Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology, 84, 776–783.
Tryfonos, C. (2023). Association of higher mediterranean diet adherence with lower prevalence of disability and symptom severity, depression, anxiety, stress, sleep quality, cognitive impairment, and physical inactivity in older adults with multiple sclerosis. J Geriatr Psychiatry Neurol, 8919887231218754.
Zhang, J., et al. (2024). Abnormal caudate nucleus activity in patients with depressive disorder: Meta-analysis of task-based functional magnetic resonance imaging studies with behavioral domain. Psychiatry Res Neuroimaging, 338, 111769.
Comments (0)